Xolair 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FFBX0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,055
Award facts
- Contract value 100% obligated
- $11,054.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $11,054.56 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on January 15, 2026, for the supply of XOLAIR (omalizumab) 150 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will deliver the product to Park Ridge, IL, with an ultimate completion date of February 6, 2026. This delivery order was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The underlying IDC, awarded on November 13, 2025, carries a $499,999,999 ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. XOLAIR is a biologic immunosuppressant used in specialty pharmaceutical applications, and this delivery order represents one of numerous orders DMS Pharmaceutical Group fulfills to support Department of Defense medical supply requirements globally.
Quick answers
Who was awarded contract SPE2DR26FFBX0?
SPE2DR26FFBX0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FFBX0 worth?
The government has obligated $11,055 on SPE2DR26FFBX0.
Is contract SPE2DR26FFBX0 an order under another contract?
Yes. SPE2DR26FFBX0 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBX0 competed?
The extent of competition for SPE2DR26FFBX0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award